Malformations and Fetal Exposures to Antiseizure Medication Polytherapies
- 9 June 2026
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 106 (11) , e218043
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Antiseizure Medication Polytherapies During Pregnancy and the Risk of Congenital MalformationsNeurology, 2026
- Use of Antiseizure Medications Early in Pregnancy and the Risk of Major Malformations in the NewbornNeurology, 2025
- Antiepileptic drug polytherapy in pregnant women with epilepsyActa Neurologica Scandinavica, 2018
- Topiramate use early in pregnancy and the risk of oral cleftsNeurology, 2018
- Antiepileptic drug combinations not involving valproate and the risk of fetal malformationsEpilepsia, 2016
- Developmental effects of antiepileptic drugs and the need for improved regulationsNeurology, 2016
- Use of topiramate in pregnancy and risk of oral cleftsAmerican Journal of Obstetrics and Gynecology, 2012
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2006